Current Value
$21.801 Year Return
Current Value
$21.801 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SANA | 47.70% | $817.16M | -42.13% | 0.00% |
HCAT | 42.39% | $419.24M | -37.31% | 0.00% |
VIR | 40.91% | $1.67B | +16.68% | 0.00% |
ACCD | 40.59% | $550.07M | -50.97% | 0.00% |
CENT | 39.84% | $2.30B | -5.35% | 0.00% |
BBSI | 39.79% | $1.07B | +47.51% | 1.83% |
CENTA | 39.72% | $1.95B | -10.25% | 0.00% |
NOVT | 39.49% | $5.30B | -5.27% | 0.00% |
AIR | 38.97% | $2.43B | +13.70% | 0.00% |
PDM | 38.12% | $1.04B | +14.50% | 6.00% |
DGII | 38.11% | $1.05B | +18.79% | 0.00% |
VNO | 37.78% | $7.20B | +37.98% | 1.98% |
BN | 37.60% | $82.83B | +40.15% | 0.59% |
CSGS | 37.34% | $1.45B | -5.20% | 2.42% |
HROW | 37.04% | $1.31B | +268.91% | 0.00% |
ACVA | 36.85% | $3.48B | +48.11% | 0.00% |
MATW | 36.75% | $919.46M | -14.44% | 3.30% |
ALDX | 36.74% | $294.18M | +53.89% | 0.00% |
BZH | 36.67% | $799.73M | -19.30% | 0.00% |
ASGN | 36.45% | $3.80B | -4.39% | 0.00% |
SeekingAlpha
Catalyst Pharmaceuticals' investment merits are bolstered by a favorable settlement announced on January 8. Read why I rate CPRX stock as a Strong Buy.
Yahoo
Catalyst (CPRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Yahoo
Catalyst struck a deal Wednesday with Teva that will prevent the generic drugmaker from knocking off Firdapse until 2035.
Yahoo
As Part of the Settlement, Teva Receives a License to Market Generic FIRDAPSE Beginning in February 2035CORAL GABLES, Fla., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that the Company and its licensor SERB S.A. (“SERB”) have entered into a
Yahoo
Arcellx shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 82.
Yahoo
A Relative Strength Rating upgrade for Neurocrine Biosciences shows improving technical performance. Will it continue?
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
IRWD | -14.35% | $633.71M | -67.41% | 0.00% |
SYPR | -13.02% | $49.73M | +2.37% | 0.00% |
K | -12.56% | $28.10B | +47.08% | 2.77% |
CODX | -12.04% | $26.50M | -40.71% | 0.00% |
PRPH | -11.05% | $15.49M | -86.76% | 0.00% |
HUSA | -10.83% | $21.99M | -1.18% | 0.00% |
PULM | -10.63% | $21.95M | +206.95% | 0.00% |
CPSH | -10.30% | $25.56M | -23.48% | 0.00% |
BACK | -9.88% | $2.56M | -43.83% | 0.00% |
FUBO | -8.61% | $1.71B | +87.18% | 0.00% |
DAVA | -8.15% | $1.39B | -59.70% | 0.00% |
FATBB | -8.08% | $88.50M | -7.04% | 10.87% |
CBOE | -7.34% | $19.99B | +5.68% | 1.23% |
LPTH | -6.92% | $124.15M | +146.46% | 0.00% |
PSQH | -6.77% | $167.01M | -23.48% | 0.00% |
TCTM | -6.60% | $6.23M | -37.75% | 0.00% |
IRBT | -6.57% | $319.34M | -65.14% | 0.00% |
MCK | -6.48% | $73.85B | +19.87% | 0.46% |
STG | -6.14% | $28.83M | -36.52% | 0.00% |
EIX | -5.72% | $25.16B | -8.91% | 4.97% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TEM | -0.01% | $5.91B | 0.00% | 0.00% |
CC | -0.06% | $2.64B | -41.57% | 5.60% |
GORV | 0.08% | $95.54M | -84.32% | 0.00% |
GRAL | -0.08% | $595.74M | +4.29% | 0.00% |
VHC | -0.13% | $28.01M | +19.97% | 0.00% |
MLCO | 0.16% | $2.28B | -33.86% | 0.00% |
RCEL | -0.18% | $227.06M | -37.27% | 0.00% |
EZPW | 0.20% | $643.78M | +38.41% | 0.00% |
ACGL | -0.20% | $33.93B | +22.06% | 0.00% |
DLTR | 0.23% | $15.68B | -46.30% | 0.00% |
SAVA | 0.24% | $136.15M | -89.21% | 0.00% |
BNED | 0.26% | $300.33M | -91.58% | 0.00% |
FRD | 0.26% | $103.52M | -8.83% | 0.98% |
BBVA | 0.27% | $58.16B | +11.47% | 7.10% |
STVN | 0.29% | $6.25B | -16.94% | 0.26% |
DOGZ | -0.47% | $528.07M | +887.62% | 0.00% |
CIG | -0.51% | $3.28B | -5.32% | 0.00% |
CASI | 0.54% | $34.98M | -57.07% | 0.00% |
CVAC | -0.56% | $944.33M | +8.51% | 0.00% |
SID | 0.57% | $1.76B | -63.36% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
RSPA | 55.00% | $270.45M | 0% |
PBE | 48.59% | $254.47M | 0.58% |
QQA | 46.21% | $147.54M | 0% |
PTH | 45.13% | $122.11M | 0.6% |
FBT | 44.66% | $1.14B | 0.56% |
XPH | 44.02% | $158.66M | 0.35% |
XBI | 43.84% | $6.43B | 0.35% |
SMMV | 42.91% | $303.68M | 0.2% |
PSC | 42.66% | $734.03M | 0.38% |
IWO | 42.51% | $12.80B | 0.24% |
SMLF | 42.39% | $1.51B | 0.15% |
OMFL | 42.20% | $5.08B | 0.29% |
IWM | 42.14% | $71.90B | 0.19% |
SMIG | 42.09% | $765.48M | 0.6% |
VTWO | 41.99% | $12.36B | 0.1% |
GSSC | 41.89% | $529.07M | 0.2% |
PRFZ | 41.78% | $2.55B | 0.39% |
VBK | 41.77% | $19.70B | 0.07% |
FNY | 41.72% | $381.17M | 0.7% |
IBB | 41.64% | $6.45B | 0.45% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -32.14% | $195.31M | 0.85% |
TAIL | -25.64% | $65.56M | 0.59% |
USDU | -14.02% | $381.18M | 0.5% |
WEAT | -11.74% | $119.67M | 0.28% |
CORN | -10.11% | $63.58M | 0.2% |
DBA | -8.01% | $790.77M | 0.93% |
UUP | -7.78% | $607.07M | 0.77% |
CTA | -7.21% | $497.20M | 0.76% |
SOYB | -5.64% | $24.83M | 0.22% |
UNG | -4.84% | $790.37M | 1.06% |
XHLF | -3.77% | $939.87M | 0.03% |
DFNM | -3.68% | $1.44B | 0.17% |
CANE | -3.07% | $12.08M | 0.29% |
KRBN | -2.89% | $194.27M | 0.85% |
XBIL | -2.31% | $641.82M | 0.15% |
PWZ | -2.09% | $705.44M | 0.28% |
GBIL | -1.79% | $5.82B | 0.12% |
MINT | -1.05% | $12.00B | 0.35% |
GSY | -0.95% | $2.43B | 0.23% |
CLOI | -0.73% | $792.86M | 0.4% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
MEAR | 0.04% | $772.54M | 0.25% |
HTAB | -0.10% | $441.48M | 0.39% |
TBLL | -0.15% | $2.00B | 0.08% |
DBO | 0.25% | $214.31M | 0.77% |
CGSM | -0.40% | $560.47M | 0.25% |
BILZ | -0.57% | $614.54M | 0.14% |
TPMN | 0.57% | $41.63M | 0.65% |
VRIG | 0.58% | $1.13B | 0.3% |
DBE | -0.63% | $48.12M | 0.77% |
HIGH | 0.63% | $281.53M | 0.52% |
IBTF | -0.65% | $2.23B | 0.07% |
CLOI | -0.73% | $792.86M | 0.4% |
SHYD | 0.85% | $311.71M | 0.35% |
GSY | -0.95% | $2.43B | 0.23% |
MINT | -1.05% | $12.00B | 0.35% |
XONE | 1.15% | $540.66M | 0.03% |
FMHI | 1.15% | $753.18M | 0.7% |
CCOR | 1.19% | $83.85M | 1.18% |
USCI | 1.21% | $193.45M | 1.07% |
HYMU | 1.78% | $254.16M | 0.35% |